YM-750
CAS No. 138046-43-2
YM-750 ( YM 750; YM-750 )
Catalog No. M27744 CAS No. 138046-43-2
YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 76 | Get Quote |
|
10MG | 125 | Get Quote |
|
25MG | 250 | Get Quote |
|
50MG | 410 | Get Quote |
|
100MG | 605 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameYM-750
-
NoteResearch use only, not for human use.
-
Brief DescriptionYM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A.
-
DescriptionYM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A.
-
SynonymsYM 750; YM-750
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138046-43-2
-
Formula Weight452.6
-
Molecular FormulaC31H36N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc(C)c(NC(=O)N(Cc2ccc-3c(Cc4ccccc-34)c2)C2CCCCCC2)c(C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Dynorphin A (1-6)
Applications Dynorphin A (1-6) H-Tyr-Gly-Gly-Phe-Leu-Arg-OH (CAS# 75106-70-6) is a useful research chemical compound.
-
Sinapaldehyde b
Sinapaldehyde has effects against 65 strains of Candida,Sinapaldehyde inhibits prostaglandin synthetase in a dose-dependent way, it dose-dependently inhibits ethyl phenylpropiolate-induced edema of the rat ear, and can inhibit electrically induced contractions of the guinea pig ileum in a dose-dependent way.
-
Etifoxine hydrochlor...
Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.